Transcriptional elongation control in developmental gene expression, aging, and disease.
BRD4
CDK9
Integrator
NELF
RNA polymerase II
SEC
SPT5
SPT6
aging
cancer
development
elongation
super elongation complex
transcription
Journal
Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571
Informations de publication
Date de publication:
16 Nov 2023
16 Nov 2023
Historique:
received:
28
07
2023
revised:
23
09
2023
accepted:
11
10
2023
medline:
27
11
2023
pubmed:
6
11
2023
entrez:
3
11
2023
Statut:
ppublish
Résumé
The elongation stage of transcription by RNA polymerase II (RNA Pol II) is central to the regulation of gene expression in response to developmental and environmental cues in metazoan. Dysregulated transcriptional elongation has been associated with developmental defects as well as disease and aging processes. Decades of genetic and biochemical studies have painstakingly identified and characterized an ensemble of factors that regulate RNA Pol II elongation. This review summarizes recent findings taking advantage of genetic engineering techniques that probe functions of elongation factors in vivo. We propose a revised model of elongation control in this accelerating field by reconciling contradictory results from the earlier biochemical evidence and the recent in vivo studies. We discuss how elongation factors regulate promoter-proximal RNA Pol II pause release, transcriptional elongation rate and processivity, RNA Pol II stability and RNA processing, and how perturbation of these processes is associated with developmental disorders, neurodegenerative disease, cancer, and aging.
Identifiants
pubmed: 37922911
pii: S1097-2765(23)00807-9
doi: 10.1016/j.molcel.2023.10.004
pii:
doi:
Substances chimiques
RNA Polymerase II
EC 2.7.7.-
Transcriptional Elongation Factors
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3972-3999Informations de copyright
Copyright © 2023. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Declaration of interests The authors declare no competing interests.